Top

Documenta Ophthalmologica

Published in:

Open Access 01-10-2015 | Original Research Article

Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson’s disease (PD)

Authors: Barbara Nowacka, Wojciech Lubiński, Krystyna Honczarenko, Andrzej Potemkowski, Krzysztof Safranow

Published in: Documenta Ophthalmologica | Issue 2/2015

Abstract

Purpose

To determine bioelectrical function and structural changes of the retina in patients with early stages of Parkinson’s disease (PD).

Materials and methods

Thirty-eight eyes of 20 patients with early idiopathic PD and 38 eyes of 20 healthy age- and sex-matched controls were ophthalmologically examined, including assessment of distance best-corrected visual acuity (DBCVA), slit lamp examination of the anterior and posterior segment of the eye, evaluation of the eye structures: paramacular retinal thickness (RT) and retinal nerve fiber layer (RNFL) thickness with the aid of OCT, and the bioelectrical function by full-field electroretinogram (ERG). Additionally, PD patients were interviewed as to the presence of dopamine-dependent visual functions abnormalities.

Results

In patients with early PD, statistically significant changes in comparison with the control group were observed in ERG. They contained a reduction in mean amplitudes of the scotopic a-wave (rod–cone response), the scotopic oscillatory potentials (OPs)—OP2 and OP3, the photopic b-wave, and a reduction in the overall index (OP1 + OP2 + OP3) and a prolongation of mean peak times of the scotopic OP1, OP2, OP3, OP4 (p < 0.05). A questionnaire concerning abnormalities of dopamine-dependent visual functions revealed that PD patients with abnormal peak times of OP1, OP2, and OP3 reported non-specific visual disturbances more frequently in comparison with PD patients with normal peak times of OPs. Other analyzed parameters of ERG, DBCVA, RT, and RNFL did not significantly differ between patients with PD and the control group.

Conclusion

In patients with early PD, bioelectrical dysfunction of the retina was observed in the ERG test, probably as a result of dopamine deficiency in the retina. The results of our study indicate that ERG may also be a useful tool for understanding the reason for non-specific visual disturbances occurring in PD patients.

Djamgoz MB, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 37:3509–3529CrossRefPubMed

Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2009) The retina in Parkinson’s disease. Brain 132:1128–1145CrossRefPubMed

Wink B, Harris J (2000) A model of the Parkinsonian visual system: support for the dark adaptation hypothesis. Vision Res 40:1937–1946CrossRefPubMed

Davidsdottir S, Cronin-Golomb A, Lee A (2005) Visual and spatial symptoms in Parkinson’s disease. Vision Res 45:1285–1296CrossRefPubMed

Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, Dawson JD (2005) Visual dysfunction in Parkinson disease without dementia. Neurology 65:1907–1913CrossRefPubMed

Price MJ, Feldman RG, Adelberg D, Kayne H (1992) Abnormalities in color vision and contrast sensitivity in Parkinson’s disease. Neurology 42:887–890CrossRefPubMed

Ikeda H, Head GM, Ellis CJ (1994) Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson’s disease and a follow up study. Vision Res 34:2629–2638CrossRefPubMed

Burguera JA, Vilela C, Traba A, Ameave Y, Vallet M (1990) The electroretinogram and visual evoked potentials in patients with Parkinson’s disease. Arch Neurobiol (Madr) 53:1–7

Nightingale S, Mitchell KW, Howe JW (1986) Visual evoked cortical potentials and pattern electroretinograms in Parkinson’s disease and control subjects. J Neurol Neurosurg Psychiatry 49:1280–1287PubMedCentralCrossRefPubMed

10.

Gottlob I, Schneider E, Heider W, Skrandies W (1987) Alteration of visual evoked potentials and electroretinograms in Parkinson’s disease. Electroencephalogr Clin Neurophysiol 66:349–357CrossRefPubMed

11.

Devos D, Tir M, Maurage CA, Waucquier N, Defebvre L, Defoort-Dhellemmes S, Destée A (2005) ERG and anatomical abnormalities suggesting retinopathy in dementia with Lewy bodies. Neurology 65:1107–1110CrossRefPubMed

12.

Krejcova H, Jerabek J, Filipova M, Bojar M, Polechova P (1985) Vestibilo-ocular and ERG changes in Parkinson patients. J Neurol 232(Suppl.):130

13.

Filipova M, Balik J, Filip V, Rodny J, Krejcova H (1979) Electroretinographic changes in patients with parkinsonism treated with various classes of antiparkinsonian drugs. Act Nerv Super 21:136–138

14.

Filipova M, Terziivanov D, Balik J, Janku I, Filip V, Stika L, Krejcova H (1981) Electroretinogram in parkinsonism and effects of l-DOPA. Act Nerv Super 23:301–302

15.

Iudice A, Virgili P, Muratorio A (1980) The electroretinogram in Parkinson’s disease. Res Commun Psychol Psychiat Behav 5:283–289

16.

Kupersmith MJ, Shakin E, Siegel IM, Lieberman A (1982) Visual system abnormalities in patients with Parkinson’s disease. Arch Neurol 39:284–286CrossRefPubMed

17.

Peppe A, Stanzione P, Pierantozzi M, Semprini R, Bassi A, Santilli AM, Formisano R, Piccolino M, Bernardi G (1998) Does pattern electroretinogram spatial tuning alteration in Parkinson’s disease depend on motor disturbances or retinal dopaminergic loss? Electroencephalogr Clin Neurophysiol 106:374–382CrossRefPubMed

18.

Garcia-Martin E, Satue M, Fuertes I, Otin S, Alarcia R, Herrero R, Bambo MP, Fernandez J, Pablo LE (2012) Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson’s disease. Ophthalmology 119:2161–2167CrossRefPubMed

19.

Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A (2004) Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 44:2793–2797CrossRefPubMed

20.

Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, Koutsandrea C (2011) Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 21:24–29CrossRefPubMed

21.

Tsironi EE, Dastiridou A, Katsanos A, Dardiotis E, Veliki S, Patramani G, Zacharaki F, Ralli S, Hadjigeorgiou GM (2012) Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease. BMC Ophthalmol 12:54PubMedCentralCrossRefPubMed

22.

Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2011) Retinal thickness in Parkinson’s disease. Parkinsonism Relat Disord 17:431–436CrossRefPubMed

23.

Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S (2010) Detection of retinal changes in Parkinson’s disease with spectral-domain optical coherence tomography. Clin Ophthalmol 4:1427–1432PubMedCentralPubMed

24.

Satue M, Seral M, Otin S, Alarcia R, Herrero R, Bambo MP, Fuertes MI, Pablo LE, Garcia-Martin E (2014) Retinal thinning and correlation with functional disability in patients with Parkinson’s disease. Br J Ophthalmol 98:350–355CrossRefPubMed

25.

Albrecht P, Müller AK, Südmeyer M, Ferrea S, Ringelstein M, Cohn E, Aktas O, Dietlein T, Lappas A, Foerster A, Hartung HP, Schnitzler A, Methner A (2012) Optical coherence tomography in parkinsonian syndromes. PLoS One 7:e34891PubMedCentralCrossRefPubMed

26.

Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2009) International Society for Clinical Electrophysiology of Vision. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 118:69–77CrossRefPubMed

27.

Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 57:289–300

28.

Jaffe MJ, Bruno G, Campbell G, Lavine RA, Karson CN, Weinberger DR (1987) Ganzfeld electroretinographic findings in parkinsonism: untreated patients and the effect of levodopa intravenous infusion. J Neurol Neurosurg Psychiatry 50:847–852PubMedCentralCrossRefPubMed

29.

Penn RD, Hagins WA (1969) Signal transmission along retinal rods and the origin of the electroretinographic a-wave. Nature 223:201–205CrossRefPubMed

30.

Stella SL Jr, Thoreson WB (2000) Differential modulation of rod and cone calcium currents in tiger salamander retina by D2 dopamine receptors and cAMP. Eur J Neurosci 12:3537–3548CrossRefPubMed

31.

Akopian A, Witkovsky P (1996) D2 dopamine receptor-mediated inhibition of a hyperpolarization-activated current in rod photoreceptors. J Neurophysiol 76:1828PubMed

32.

Krizaj D, Gábriel R, Owen WG, Witkovsky P (1998) Dopamine D2 receptor-mediated modulation of rod-cone coupling in the Xenopus retina. J Comp Neurol 398:529–538PubMedCentralCrossRefPubMed

33.

Shulman LM, Fox DA (1996) Dopamine inhibits mammalian photoreceptor Na+, K+ -ATPase activity via a selective effect on the alpha3 isozyme. Proc Natl Acad Sci U S A 93:8034–8039PubMedCentralCrossRefPubMed

34.

Nowak JZ, Sek B, Schorderet M (1991) Dark-induced supersensitivity of dopamine D-1 and D-2 receptors in rat retina. NeuroReport 2:429–432CrossRefPubMed

35.

Jackson CR, Capozzi M, Dai H, McMahon DG (2014) Circadian perinatal photoperiod has enduring effects on retinal dopamine and visual function. J Neurosci 34:4627–4633PubMedCentralCrossRefPubMed

36.

Krizaj D (1993) Witkovsky P. Effects of submicromolar concentrations of dopamine on photoreceptor to horizontal cell communication Brain Res 627:122–128PubMed

37.

Wachtmeister L, Dowling JE (1978) The oscillatory potentials of the mudpuppy retina. Invest Ophthalmol Vis Sci 17:1176–1188PubMed

38.

Yonemura D, Kawasaki K (1979) New approaches to ophthalmic electrodiagnosis by retinal oscillatory potential, drug-induced responses from retinal pigment epithelium and cone potential. Doc Ophthalmol 48:163–222CrossRefPubMed

39.

Heynen H, Wachtmeister L, van Norren D (1985) Origin of the oscillatory potentials in the primate retina. Vision Res 25:1365–1373CrossRefPubMed

40.

Dong CJ, Agey P, Hare WA (2004) Origins of the electroretinogram oscillatory potentials in the rabbit retina. Vis Neurosci 21:533–543CrossRefPubMed

41.

Zhang DQ, Zhou TR, McMahon DG (2007) Functional heterogeneity of retinal dopaminergic neurons underlying their multiple roles in vision. J Neurosci 27:692–699CrossRefPubMed

42.

Hempel FG (1973) Modification of the Rabbit Electroretinogram by Reserpine. Ophthalmic Res 4:65–75CrossRef

43.

Gutiéerrez O, Spiguel RD (1973) Oscillatory potentials of the cat retina: effects of adrenergic drugs. Life Sci 13:991–999CrossRef

44.

Karwoski CJ, Xu X (1999) Current source-density analysis of light-evoked field potentials in rabbit retina. Vis Neurosci 16:369–377CrossRefPubMed

45.

Green DG, Kapousta-Bruneau NV (1999) A dissection of the electroretinogram from the isolated rat retina with microelectrode and drugs. Vis Neurosci 16:727–741CrossRefPubMed

46.

Masu M, Iwakabe H, Tagawa Y, Miyoshi T, Yamashita M, Fukuda Y, Sasaki H, Hiroi K, Nakamura Y, Shigemoto R, Takada M, Nakamura K, Nakao K, Katsuki M, Nakanishi S (1995) Specific deficit of the ON response in visual transmission by targeted disruption of the mGluR6 gene. Cell 80:757–765CrossRefPubMed

47.

Dong CJ, Hare WA (2000) Contribution to the kinetics and amplitude of the electroretinogram b-wave by third-order retinal neurons in the rabbit retina. Vision Res 40:579–589CrossRefPubMed

48.

Bodis-Wollner I (2003) Neuropsychological and perceptual defects in Parkinson’s disease. Parkinsonism Relat Disord 9(Suppl 2):S83–S89CrossRefPubMed

49.

Gonon FG (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24:19–28CrossRefPubMed

50.

Floresco SB, West AR, Ash B, Moore H, Grace AA (2003) Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 6:968–973CrossRefPubMed

Title: Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson’s disease (PD)
Authors: Barbara Nowacka
Wojciech Lubiński
Krystyna Honczarenko
Andrzej Potemkowski
Krzysztof Safranow
Publication date: 01-10-2015
Publisher: Springer Berlin Heidelberg
Published in: Documenta Ophthalmologica / Issue 2/2015
Print ISSN: 0012-4486
Electronic ISSN: 1573-2622
DOI: https://doi.org/10.1007/s10633-015-9503-0

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson’s disease (PD)

Abstract

Purpose

Materials and methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2015

GUCY2D mutations in a Chinese cohort with autosomal dominant cone or cone–rod dystrophies

A method for estimating intrinsic noise in electroretinographic (ERG) signals

Reproducibility in the global indices for multifocal visual evoked potentials and Humphrey visual fields in controls and glaucomatous eyes within a 2-year period

Long-term follow-up of two patients with oligocone trichromacy

Objective measurement of visual resolution using the P300 to self-facial images

The value of multifocal electroretinography to predict progressive visual acuity loss in early AMD